29 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... with Community-Acquired ... fluoroquinolone #IDSA ... Regimen #Management #Guidelines ... #pharmacology
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... #pharmacology # ... #medications #IDSA ... #Guidelines
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Tuberculosis - IDSA ... Guidelines # ... #medications #pharmacology ... #IDSA #Guidelines ... #Treatment
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
and Management - IDSA ... Guidelines 1) Antibiotics ... Consider: Spine, CNS, liver ... #Candidemia #IDSA ... #candidiasis #treatment
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Severe Community Acquired ... Pneumonia - Typhoid fever ... severe community-acquired ... InfectiousDiseases #Infections #Pharmacology ... #Management #Treatment
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... the perceived level ... LAMA #LABA #ICS #Guidelines
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
Antibiotic treatment ... • Community acquired ... • Community acquired ... days • Scarlet fever ... #pharmacology #
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
mucus, Abd pain, Fever ... can be community-acquired ... Tx Management (IDSA ... /severe CDI IDSA ... Guideline: https
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... Agents for Treatment ... infection Episode #Pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... for effective treatment ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology